Trials / Completed
CompletedNCT01848535
Effect of GOS Supplementation on Amoxicillin-treated Gut Microbiota From Healthy Adults
Effect of Galacto-Oligosaccharides Supplementation on Amoxicillin-treated Gut Microbiota From Healthy Adults : a Proof of Principal Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Wageningen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Prebiotics are thought to be a potential means to prevent antibiotic-associated diarrhoea because of their ability to stimulate beneficial bacteria. In-vitro results showed a promising recovery of Bifidobacteria combined with an increase of Short Chain Fatty Acids (SCFA) upon Galacto-oligosaccharides (GOS) supplementation to amoxicillin-treated microbiota. As the microbiota is nowadays considered as a key factor in human health, a further understanding of the gut microbiota functioning in-vivo is essential. This understanding of the use of specific prebiotics may possibly be beneficial in the prevention or recovery of antibiotic-disturbed microbiota. As the effects of GOS supplementation on the microbiota composition and activity from healthy adults receiving amoxicillin have never been tested in-vivo, the investigators propose the current study as a proof of principle. Objective: To explore whether the promising effects of GOS supplementation on the composition and activity of gut microbiota from healthy adults as found by in-vitro, can also be observed in-vivo. Study population: 10 healthy men and women volunteers, 18 - 40 yr old
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | GOS addition | GOS (2.5g 3x per day) supplemented during 12 days |
| DIETARY_SUPPLEMENT | Placebo | Maltodextrine(2.5g 3x per day) supplemented during 12 days |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2013-05-07
- Last updated
- 2013-11-20
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01848535. Inclusion in this directory is not an endorsement.